Dönmez Çakıl, Y. (2023) “The effects of low-dose sorafenib on epithelial-mesenchymal transition and multidrug resistance markers in HepG2 cell line”, The European Research Journal, 9(2), pp. 367–374. doi:10.18621/eurj.1206680.